Source: centralcharts

Press Release: Organogenesis : Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CANTON, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (the "Company") (Nasdaq: ORGO), a leading regenerative medicine company focused

Read full article »
Organogenesis's Competitors | Organogenesis's News | Organogenesis's Financials
Stay up-to-date with the latest news on Organogenesis
Annual Revenue
$100-500M
Employees
500-1.0K
Gary S. Gillheeney Sr.'s photo - President & CEO of Organogenesis

President & CEO

Gary S. Gillheeney Sr.

CEO Approval Rating

76/100

Read more
Stay up-to-date with the latest news on Organogenesis